INS and early-onset autosomal dominant Alzheimer disease: Given the fact that diabetes is a chronic disease and metabolic factors such as serum glucose, insulin, and glucagon are altered by disease progression [15, 16], new information about how the brain responds to disease progression could provide insight into the development of Alzheimer’s disease in patients with diabetes.